Alphabet Inc.'s Form 4 filing
Prime Medicine, Inc. (PRME) · filed Aug 5, 2025
- Accession no.
- 0001415889-25-021025
- Filed
- Aug 5, 2025, 4:07 PM ET
- Trade date
- Aug 1, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $4.95M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Alphabet Inc.CIK 0001652044 | 10% Owner |
| GV 2021, L.P.CIK 0001861202 | 10% Owner |
| GV 2021 GP, L.L.C.CIK 0001861206 | 10% Owner |
| GV 2021 GP, L.P.CIK 0001861216 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Common Stock | PPurchaseAcquired | +1,500,000 | $3.30 | +$4,950,000 | 3,262,440 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.